Introduction
Translocating already folded globular proteins of different sizes and shapes across a biological membrane, while ensuring minimal leakage of that membrane, must be a difficult task. Perhaps for this reason, many protein translocation pathways use strategies to maintain their substrates in an unfolded state [1] [2] [3] [4] . In this way, they can rely on vastly smaller translocation pores/channels and avoid the different size/shape problem -an extended polypeptide chain, be it from a 10-kDa or a 250-kDa protein, has always a roughly constant diameter of 0.4-0.6 nm [5] . But not all protein translocases use this principle. A notable example is found in peroxisomes, small single membrane-bound organelles present in almost all eukaryotic organisms [6] . Indeed, peroxisomal matrix proteins acquire their tertiary structure (or at least part of it) already in the cytosol, prior to the membrane translocation step ([7,8] ; reviewed in ref. [9] ). Actually, in a few cases, even oligomeric proteins can go across the peroxisomal membrane, although this type of transport is probably inefficient [10] [11] [12] [13] [14] . The mechanistic details of protein translocation across the peroxisome membrane are still being unveiled but, nevertheless, the data gathered in recent years start to provide a reasonably clear picture, as discussed below.
Peroxisomal targeting signals, their receptors, and the import machinery
The peroxisomal matrix is probably one the most protein-rich compartments of the cell [15] . The intraperoxisomal concentration of some proteins is so large that they actually crystallize inside the organelle [16] [17] [18] . Despite this, the protein complexity of the peroxisomal matrix is rather small. For instance, in mammals, there are only about 50 different proteins in the organelle matrix [19] [20] [21] . These proteins are mainly enzymes participating in metabolic pathways such as synthesis of plasmalogens and bile acids, b-oxidation of very long chain fatty acids, and detoxification of glyoxylate and ROS [22, 23] .
All peroxisomal matrix proteins are synthesized on cytosolic ribosomes and post-translationally imported into the organelle [24] . They harbor one of two known peroxisomal targeting signals (PTS), namely the PTS type 1, a short C-terminal sequence frequently ending with SKL [25, 26] , or the PTS2, a degenerated nonapeptide present at the N termini of some proteins [27, 28] . Both types of proteins are transported to the organelle by shuttling receptors [26, 29] . In higher eukaryotes, mammals included, the receptor/transporter is PEX5, which alone or with the help of the ancillary factor PEX7 binds PTS1 proteins and PTS2 proteins, respectively [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . Lower eukaryotes, such as yeasts and fungi, may have additional PEX5-like proteins, such as PEX9, a receptor for a specific set of PTS1 proteins, and PEX18, PEX20, or PEX21, three proteins displaying structural/functional similarities to the N-terminal half of PEX5 and involved in sorting PTS2 proteins to the organelle [40] [41] [42] [43] [44] . These receptors are believed to function similarly to canonical PEX5 and, therefore, data on these proteins have also been valuable for our understanding of PEX5 (see ref. [45] for a review on this issue).
After binding a cargo protein in the cytosol, PEX5 or the PEX5.PEX7 complex interacts with the peroxisomal membrane docking/translocation module (DTM; Fig. 1 ) a transmembrane protein complex comprising PEX13 and PEX14 and the RING finger proteins PEX2, PEX10, and PEX12 [46] [47] [48] [49] . This interaction is complex and still poorly understood but it ultimately results in the insertion of the receptor into the DTM [47, 50, 51] . In fact, at this stage of the pathway, the ancillary factor PEX7 is partially exposed to the peroxisomal matrix milieu, whereas PEX5 displays a transmembrane topology, exposing a small N-terminal fragment into the cytosol and a portion of its polypeptide chain into the peroxisomal matrix [51] [52] [53] . It is during this receptor insertion step that cargo proteins are pushed across the DTM and released into the organelle matrix (Fig. 1) [46, 54] . Notably, none of these steps requires ATP hydrolysis or a membrane potential -the complete cargo transport process is Fig. 1 . The PEX5-mediated import of peroxisomal matrix proteins. Cytosolic PEX5 binds newly synthesized matrix proteins (cargo), an interaction that sets up the receptor for a productive interaction with the peroxisomal DTM. Cargo-loaded PEX5 docks at this membrane complex, and then becomes inserted into it while pushing and releasing the cargo protein into the organelle lumen. All these events rely on protein-protein interactions alone. DTMembedded PEX5 is then monoubiquitinated at a conserved cysteine residue thus becoming a substrate for the AAA ATPases of the REM which, powered by ATP hydrolysis, mechanically extract monoubiquitinated PEX5 back into the cytosol. Finally, PEX5 is rapidly deubiquitinated and a new protein transport cycle can start.
apparently driven by protein-protein interactions [46, 54, 55] . The need for ATP comes only at the next steps, when the machinery is reset, that is, when the receptor is extracted back into the cytosol thus freeing the DTM for another protein import event [55] . This involves (a) monoubiquitination of PEX5 at a conserved cysteine residue located near the N terminus of the protein by the RING peroxins of the DTM [56] [57] [58] , (b) extraction of monoubiquitinated PEX5 into the cytosol by the ATP-dependent mechanoenzymes PEX1 and PEX6, a step that also releases PEX7 from the DTM [51, 55, [59] [60] [61] , and, finally, (c) the rapid deubiquitination of Ub-PEX5 in the cytosol [62] [63] [64] .
The functional/structural properties of PEX5
Given the mechanism described above -a soluble receptor pushes a cargo protein all the way through the DTM into the organelle matrix -it is evident that part of the answer to understand how folded proteins are translocated across the organelle membrane relies on the receptor itself, PEX5.
Over the last few years, a wealth of information has become available on PEX5, particularly on the mammalian protein in which we focus here. We note that the mammalian PEX5 transcript undergoes alternative splicing yielding two major isoforms that differ by only 37 amino acid residues, the so-called large and small isoforms of PEX5, respectively [34, 35] . Both isoforms transport PTS1 proteins to the organelle but only the large one is capable of transporting also PTS2 proteins [34, 35, 41] .
PEX5 is a~70-kDa monomeric protein comprising two structurally distinct domains: (a) an intrinsically disordered N-terminal half harboring a large number of small motifs/modules involved in protein-protein interactions [65] [66] [67] [68] [69] [70] [71] [72] [73] ; and (b) a globular C-terminal half comprising two sets of three tetratricopeptide repeats (hereafter referred to as the TPR domain; Fig. 2 [32, 74, 75] ).
The intrinsically disordered N-terminal half of PEX5 holds most of the functions of the receptor. Indeed, it is in this region that reside all the necessary and sufficient domains required for the interaction of PEX5 with the DTM, recognition and import of PTS2 proteins (in the large isoform of PEX5 only), monoubiquitination of PEX5 and its export by the receptor export module (REM) [41, 42, 47, 66, 67, 76, 77] . In addition, there are also several data suggesting that this domain interacts with several PTS1 proteins [78] [79] [80] [81] [82] [83] although the main binding site for this type of cargo proteins resides in the C-terminal half of PEX5 (see below).
The existence of so many and diverse functions in the N-terminal half of PEX5, a~300 amino acid residue long protein domain, is explained by its intrinsically disordered nature and by the fact that all these functions are mediated by multiple independent binding sites (Fig. 2) . Many of these are relatively small and therefore can be classified as 'short linear motifs' (SLiMs [84] ). SLiMs are 3-10 amino acids long functional modules common in intrinsically disordered proteins/domains that 'primarily bind onto the surfaces of globular proteins' [85] . Others are longer and might belong to the 'Molecular Recognition Features' (MoRFs; [86] ) or 'preformed structural elements' (PSEs [87] ) families. These are defined as 10-70-amino acid-long domains that mediate protein-protein interactions and differ by the fact that the former undergo a disorder-to-order transition upon binding whereas the latter present similar/identical conformations in the bound and unbound states [85] . Fig. 2 . Structural/functional domains in the large isoform of mammalian PEX5. The intrinsically disordered N-terminal half of PEX5 (zig-zag purple line) appended to the structured TPR domain present in its C-terminal half (PDB file: 1FCH; [74] ) is shown. The two halves of PEX5 are drawn approximately at the same scale. Note that the N-terminal half of PEX5 has a premolten globule-like structure; it is drawn here as an extended polypeptide chain simply for clarity. Cysteine 11 (in grey), the eight pentapeptide motifs (in black), the PTS2/PEX7-binding MoRF (orange) and the second PEX7-binding site (blue) are indicated.
Ten SLiMs/MoRFs/PSEs are presently known in the N-terminal half of the large isoform of mammalian PEX5. The majority of them are the so-called pentapeptide motifs [66, 67, 88] . These SLiMs are best known as mediators of interactions with two DTM components, PEX13 and PEX14 [65] [66] [67] [70] [71] [72] [73] , but some of them may also modulate or even participate in interactions with PTS1 proteins [78, 79, 82, 83] . Another domain present in the N-terminal half of PEX5 was structurally characterized in the yeast PEX5-like protein PEX21 and shown to interact with both the PTS2 sequence and PEX7 [41, 89] . This is ã 70-amino acid-long domain comprising three ahelices and a small three-stranded b-sheet, a structure that is probably formed upon complex formation [89] . Finally, this MoRF/PSE is followed by a short and extended domain that interacts with PEX7 at a second site [89] .
The list of SLiMs/MoRFs/PSEs in the N-terminal half of PEX5 is probably not complete yet. For instance, it is likely that there is a still unidentified small motif near cys11 of PEX5 to ensure that this residue is presented correctly to the RING E3 that monoubiquitinates DTM-embedded PEX5. Also, there is now ample evidence supporting the existence of an intramolecular cross-talk between the N-and C-terminal halves of PEX5 (as part of an autoinhibitory mechanism; see below), and although we still do not know how such cross-talk is established, it might well involve additional SLiMs/MoRFs/PSEs.
In functional terms, the globular C-terminal TPR domain of PEX5 is much simpler. Its chief role is to provide the main binding site for PTS1 proteins. Indeed, it is in a cavity formed by the two sets of three TPRs that the PTS1 peptide binds [74, 90, 91] . This domain is of utmost importance for the PTS1-mediated import pathway because mutations in the TPR domain or its deletion from PEX5 result in a generalized impairment of the PTS1-mediated protein import pathway [32, 35, 41] . But there are exceptions, that is, PTS1 proteins that can still reach the organelle in cells expressing truncated forms of PEX5 lacking its TPR domain [78, 79, 83, 92] . Clearly, the intrinsically disordered N-terminal half of PEX5 also interacts with PTS1 cargo proteins, as discussed in more detail below.
Besides providing the main binding site for most PTS1 proteins, the TPR domain of PEX5 has only one other known role -it is a cis-acting repressor of the N-terminal half of PEX5 regarding its capacity to engage in interactions with the DTM [47, 93] . Indeed, using a cell-free in vitro system that recapitulates all the steps of the PEX5-mediated protein import pathway (and in which PTS2 proteins are almost absent), it was shown that insertion of (full-length) PEX5 into the DTM requires the presence of available PTS1 proteins [46, 47, 54] . No such PTS1 cargodependence was observed for truncated PEX5 molecules lacking the TPR domain and for a full-length PEX5 species harboring a single missense mutation in this domain which abolishes its PTS1-binding capacity [47, 76, 94] . Thus, in the absence of a cis-linked functional TPR domain, the N-terminal half of PEX5 interacts with the DTM in an unregulated, constitutive manner.
The molecular basis for the allosteric mechanism controlling the DTM-binding capacity of the N-terminal half of PEX5 is still unknown. As mentioned above, it is possible that the N-terminal half of PEX5 interacts with the TPR domain via a still unidentified SLiM/MoRF/PSE, and that this interaction is no longer favored when a PTS1 protein binds to the TPR domain, thus releasing the N-terminal half of PEX5 from the inhibitory action of the TPR domain [93, 94] . The finding that recombinant proteins comprising each of these two domains of PEX5 can interact in vitro favors such a possibility [95] . However, it remains plausible that binding of a PTS1 protein to the TPR domain triggers conformational changes in the Nterminal half of PEX5 [69, 94] , not by destroying specific physical contacts between these two domains of PEX5, but rather by changing the conformational energy landscape of the N-terminal half of PEX5. In this scenario, the conformation of the two halves of the protein are energetically coupled and binding of a cargo protein to the TPR domain alters the conformational ensemble of PEX5, strongly populating a state that now favors the interaction of its N-terminal half with the DTM. Regulatory mechanisms of this kind, such as the so-called dynamic allostery or ensemble models of allostery, are increasingly being found in many intrinsically disordered proteins [96, 97] .
The PEX5-cargo protein interaction
With only a few exceptions [e.g., sterol carrier protein 2 (SCP2) and L-bifunctional protein], most peroxisomal matrix proteins are oligomers in their native state [98] . This fact, together with the seeming absence of chaperones in the peroxisomal matrix ([19-21] ; but see below) and earlier findings showing that peroxisomes can import already oligomerized proteins [13, 14] led to the idea that most peroxisomal matrix proteins are imported into the organelle only after chaperoneassisted oligomerization in the cytosol. However, recent data suggest that this type of transport is inefficient and not always possible, and that many oligomeric proteins actually arrive at the peroxisomal matrix still as monomers [10, 82, [99] [100] [101] . The experimental data supporting this notion are numerous and have been reviewed recently [9] , but of relevance here are some observations on three prominent oligomeric proteins of mammalian peroxisomes -catalase, urate oxidase, and acyl-CoA oxidase I -which together comprise 30% of the protein found in rodent liver peroxisomes [102, 103] . Experiments using a mammalian in vitro protein synthesis system revealed that these proteins are folded into soluble/globular monomers shortly after their synthesis [10, 82] . In the absence of PEX5, all these proteins can homooligomerize yielding the native enzymes. However, when PEX5 is added to the system, oligomerization is blocked. Furthermore, in agreement with earlier data on the import of plant peroxisomal isocitrate lyase [11] , it was found that the monomeric versions of acylCoA oxidase I and urate oxidase are far better substrates for the peroxisomal import machinery than the corresponding oligomeric proteins [10] . Apparently, besides a role as a shuttling receptor, PEX5 is also a cytosolic chaperone/holdase, maintaining many of its cargoes in an import-competent conformation.
Interestingly, biophysical characterization of several PEX5-cargo protein complexes revealed that, although they present the expected molecular masses for a 1:1 complex, they all display abnormally large hydrodynamic radii [69, 82, 104] . This suggests that binding of a cargo protein by PEX5 is not accompanied by a global disorder-to-order transition in the N-terminal half of PEX5, a property that may have functional implications not only at the level of the PEX5-cargo protein complex but also later in the pathway, when the receptor-cargo protein complex interacts with the DTM (see below). For instance, as suggested recently [93] , this PEX5 domain may behave as an entropic bristle [105] , sweeping out other proteins from the vicinity of the cargo protein it binds, thus explaining the inhibitory effect of PEX5 on cargo oligomerization. However, it should be noted that this is not the only mechanism behind the chaperone/holdase function of PEX5, because the N-terminal half of PEX5 also interacts directly with cargo proteins [78, 79, 82] . In fact, the N-terminal half of PEX5 alone can inhibit catalase oligomerization in vitro, although in a much less potent manner than the full-length protein [82] .
The capacity of the N-terminal half of PEX5 to interact with cargo proteins is not a mammalianspecific property. Actually, such a property was first demonstrated many years ago for yeast proteins [78, 79, 92] . For instance, deletion of the PTS1 signal in several peroxisomal matrix proteins does not completely abrogate their import into the organelle, suggesting that the interaction between the TPR domain of PEX5 and the PTS1 peptide is not the sole determinant for correct sorting [78, 106, 107] . More importantly, it was shown that yeast strains expressing a truncated PEX5 lacking the TPR domain can still transport some PTS1 proteins to the organelle [78, 79, 92, 106] . Data on yeast acyl-CoA oxidase [78, 92] and carnitine acetyl-transferase [106] are particularly interesting here [81] because mapping the PEX5 N-terminal regions required for their transport to the peroxisome revealed that although these regions overlap they are not identical. Apparently, the interactions between the N-terminal half of PEX5 and different cargoes involve different regions/conformations of this PEX5 domain raising the possibility that although these interactions are probably of the chaperone-client type [82, 108] , they are also somewhat cargo specific. Given the large variety of peroxisomal matrix protein repertoires across evolution and the fact that the primary structure of the N-terminal half of PEX5 is poorly conserved, it would be interesting to determine whether this region of PEX5 and the corresponding cargoes display signs of co-evolution.
A thorough understanding of the PEX5-cargo protein interaction is not possible without knowing some of its basic parameters such as K d , k on , and k off . Unfortunately, the data presently available for PEX5- [7, 12, 24] , this stability implies that there must be a mechanism to disrupt the PEX5-cargo protein interaction in an expedite manner, after the receptorcargo complex enters the DTM. A priori one could envisage that an ATP-dependent chaperone might be involved here. However, the only protein that could potentially play such a role, the peroxisomal Lon protease/chaperone (LonP2 in mammals), is not involved in peroxisome matrix protein import but rather in protein quality control [112] [113] [114] . Furthermore, all the available evidence suggests that translocation of cargo proteins across the organelle membrane and their release into the matrix do not require ATP hydrolysis [46, 51, 54, 55] . Thus, it is likely that disruption of the PEX5-cargo protein interaction is achieved by allosteric regulation exerted by a PEX5-interacting DTM component. Some data suggesting that PEX14 may be this component have been described [82, 115] but other DTM components (e.g., PEX13 and/or PEX12, and also PEX8 in yeasts [116] [117] [118] [119] [120] ) might also be involved.
PEX5, the translocator
Due to its intrinsically disordered nature, PEX5 is extremely sensitive to proteases, a property that is maintained when the receptor binds a PTS1 protein [69] . However, this sensitivity is lost when the receptor becomes inserted into the DTM -at this stage, only a small 2-3-kDa fragment from the N terminus of the receptor can be removed upon protease treatment of intact organelles [50, 52] . This change in behavior does not mean that PEX5 undergoes a disorder-order transition at the DTM, yielding a globular/proteaseresistant conformation, because when the organelle membrane is disrupted by sonication, a procedure that does not affect the interaction of PEX5 with the DTM, the protease sensitivity of PEX5 is recovered [50, 52] . Thus, it is likely that, also at the DTM, the receptor maintains much of its intrinsic disorder. The PEX5-DTM interaction involves the pentapeptide motifs present in the N-terminal half of PEX5 on one side, and the intrinsic membrane proteins PEX14 and PEX13, on the other [65] [66] [67] 69, 70, 72, 88] . All eight pentapeptide motifs of PEX5 (numbered 0-7 from the N-to the C terminus) can interact individually with the so-called N-terminal domain of PEX14 (NTD), a globular 50 amino acid residue domain present in the N-terminal region of PEX14 [66, 72, 88] . These interactions are quite strong with K d values in the nM range. Furthermore, considering that there are several molecules of PEX14 per DTM, the PEX5-DTM interaction is also avidity driven (see also below) [49, 67, 104, 121, 122] . Interestingly, it was recently shown that the interaction between recombinant PEX5 and PEX14 NTD is stable at pH 11.5 [76] . This finding provided the rationale to understand a long-known, but intriguing, property of DTM-embedded PEX5, namely its resistance to alkaline extraction [33, 50, 75, 123] , a property generally attributed to intrinsic membrane proteins [124] . The membrane topology of PEX14 has been a subject of some controversy (see ref. [125] for a review). However, most of the available evidence suggests that PEX14 is a bitopic membrane protein with a N in -C out topology, thus possessing its NTD inside the peroxisome [122, [125] [126] [127] .
The interaction between PEX5 and PEX13 is not so well documented. In mammals, the interaction probably involves pentapeptide motifs 2-4 of PEX5 and two distinct domains in PEX13, one in the N-terminal third of the protein [67] which comprises a rather long putatively disordered region (see below and Fig. 3) , and the other in the second half of PEX13 [69] , a region comprising an Src homology 3 (SH3) domain [128] . The K d (s) of these interactions are unknown. In yeast, only the interaction involving the SH3 domain of PEX13 and the N-terminal half of PEX5 has been documented [65, 70, 71] . This interaction involves a pentapeptide motif in PEX5 and is relatively weak in solution displaying a K d of 36 lM [129] . Both the N-and C terminus of PEX13 have been described as being exposed into the cytosol [130, 131] . However, recent data from our laboratory suggest that the C-terminal SH3 domain of mammalian PEX13 actually faces the organelle matrix [127] .
An important property of the pentapeptide motifs of PEX5 is that none of them is absolutely required for the function of PEX5. Indeed, mutation or deletion of just a few pentapeptide motifs results in a gradual change in PEX5 activity both in vivo and in vitro; one has to remove/mutate several of these motifs to completely inactivate PEX5 [47, 66, 67, 76, 88] . Furthermore, two nonoverlapping PEX5 fragments, both possessing pentapeptide motifs can still interact with the DTM in a competitive manner, although the efficiency with which they enter the DTM is clearly lower than the one observed with the full-length receptor [76] . Finally, in vitro titration experiments using rat liver peroxisomes revealed that each binding site at the DTM available to interact with one molecule of full-length PEX5 can be occupied simultaneously by more than one artificially truncated PEX5 fragment [76] . Altogether, these findings indicate that the PEX5-DTM interaction is multivalent and that the DTM-interacting motifs in PEX5 are, at least partially, equivalent and redundant, strongly suggesting that the PEX5-DTM interaction is to some degree fuzzy [76, [132] [133] [134] .
Disorder in the DTM
Protein disorder in the protein import machinery is probably not limited to PEX5. Indeed, analyses of DTM components using disorder-prediction algorithms (Fig. 3 ) [135] [136] [137] suggest that two of its main subunits, PEX13 and PEX14, are particularly enriched in disordered domains. In agreement with this, both proteins are very sensitive to proteases [50, 122] , an inconvenient property when isolating organelles or purifying protein complexes [49] .
The location of the disordered regions in both PEX13 and PEX14 is interesting. For PEX14, a major disordered region is found between the PEX5-binding NTD and its sole transmembrane domain (Fig. 3) , suggesting that DTM-embedded PEX5 is bound in a flexible manner inside the protein translocation pore. The other main disordered region of PEX14 is located after its coiled-coil domain, and encompasses most of the cytosol-exposed C-terminal end of the protein. Importantly, data from yeast suggest the existence of a weak PEX5-binding site in this domain of PEX14, which is probably involved in docking of the PEX5-cargo protein complex at the DTM ( [73, 138] ; see also below).
The major disordered domain of PEX13 resides at its N-terminal end which, as stated above, is exposed into the cytosol [130, 131] . In the mammalian protein, this is a~70-amino acid residue-long region particularly enriched in proline and glycine residues. Interestingly, different compositions are observed in this domain of PEX13 from other organisms. For instance, in yeast PEX13, this disordered domain is longer (~105 amino residues) and enriched in serine, asparagine, and proline residues. Apparently, the absence of structure and not the amino acid composition is the important feature of this PEX13 domain. As with PEX14, there is also evidence suggesting that there are multiple molecules of PEX13 per DTM [48, 49, 139] . Thus, it seems that the DTM is decorated at its cytosolic face with multiple disordered strands/filaments from both PEX14 and PEX13 (Fig. 4) , suggesting that the cytosolic extensions of these two DTM components engage into long-distance interactions with the cytosolic PEX5-cargo protein complex. This might increase the association rate of the PEX5-cargo protein complex with the cavity of the DTM, where the stronger interactions that are then established between PEX5 and PEX13/PEX14 lead to the release of the cargo protein into the peroxisome matrix. Recruitment mechanisms of this type (e.g., the 'fly-casting' mechanism) involving the intrinsically disordered phenylalanineglycine domains of nucleoporins and karyopherins have been proposed for nucleocytoplasmatic transport [140] .
The 'elephant in the room' -the architecture of the DTM All the data collected until now indicate that PEX14 and PEX13 are important components of the peroxisomal protein translocation pore. The fact that they are transmembrane proteins possessing PEX5-interacting Fig. 3 . Prediction of intrinsic disordered regions in DTM components using PONDR â . The PONDR â -VLXT scores calculated for human peroxins that comprise the DTM -PEX14, PEX13, and the RING peroxins PEX12, PEX10 and PEX2 -are plotted as a function of amino acid residues. The default threshold value (0.5; black horizontal line) above which a protein region is considered as disordered, is also shown. A schematic representation of each peroxin is presented below the corresponding graphs, where putative transmembrane domains predicted by PRALINE TM (light blue [155] ) and the known globular domains (dark blue) are indicated. CC, coiled coil.
domains located on both sides of the peroxisomal membrane together with their capacity to form homooligomers [48, 121, 122, 139] , a suitable property to build pore structures, are some of the arguments supporting this idea [65] [66] [67] [69] [70] [71] [72] [73] 138] . However, we are still lacking detailed structural data for PEX13 and PEX14, and thus whether or not they have the required transmembrane amphiphilic domains necessary to build the hydrophilic pore used by PEX5 to deliver cargo proteins to the organelle matrix remains unknown. To complicate this matter further, there are some data from Arabidopsis thaliana and Hansenula polymorpha suggesting that a residual peroxisomal protein import is still possible in the absence of PEX14, arguing against a major structural role of PEX14 in the hydrophilic pore [39, 141, 142] . The fact that no PEX14 gene has been detected so far in the genomes of some peroxisome-containing organisms [143, 144] might also support this view.
There are similar problems with PEX13. Indeed, not all peroxisome-containing organisms seem to have PEX13 [143] [144] [145] and in some that probably have, the primary structure of the putative PEX13 has diverged so much that its name has been questioned, as is the case of plant PEX13 [146] . Thus, if credit is given to all these observations, we have to conclude that either other proteins can partially compensate the absence of PEX13 or PEX14 in those organisms (e.g., PEX17, a yeast-specific DTM component, displays structural similarities to PEX14; [147, 148] ), or the role of building the transmembrane hydrophilic pore rests on the RING peroxins. These have multiple transmembrane domains, some of which are amphipathic, and we are not aware of a peroxisome-containing organism lacking all three RING peroxins [143] [144] [145] . If true, this would mean that the RING peroxins are more similar to some of the E3 ubiquitin ligases functioning in the endoplasmic reticulum-associated protein degradation pathway, such as HRD1, a possible protein-conducting channel [149] , than presently assumed, as in fact hypothesized several years ago [143, 145] . Clearly, there is still a long way to go to understand this important aspect of protein translocation across the peroxisomal membrane.
Conclusion
Here, we provide a general perspective on the peroxisomal protein import machinery trying to infer the role of the intrinsic disorder that characterizes several of its components. Although we are still missing important information to fully understand this machinery, the data collected over the many years of research start to unveil its basic principles. It is becoming apparent that the peroxisomal import machinery uses a combination of d ej a vu strategies such as those used to transport cargoes into and out of the nucleus [150] , and to extract defective proteins from the ER for proteasomal degradation [143, 145, 151] or even those employed by bacteria to secrete folded proteins across their membrane(s) [82, [152] [153] [154] . Still, it is also clear that the peroxisomal import machinery conjugates all these strategies in unique ways and that the thorough characterization of its mechanism will keep us busy for many years. Fig. 4 . Model of the peroxisomal matrix protein translocon. The DTM is a large cavity-forming protein assembly containing several intrinsic disordered domains. Some of these are exposed into the cytosol, and thus might increase the capture radius for cytosolic PEX5-cargo protein complexes. This initial interaction (1st), albeit of low affinity, would increase the rate of the second interaction (2nd; for example, through a 'fly-casting' mechanism) which results in the insertion of the PEX5-cargo protein complex into the cavity of the DTM with the concomitant release of the cargo into the organelle lumen. The identities of the protein domains that comprise the transmembrane amphipathic pore are unknown. 
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